CBT-I as Early Intervention of Mood Disorders
Cognitive Behavioral Therapy for Insomnia as a Transdiagnostic Early Intervention of Mood Disorders: A Randomized Controlled Trial
1 other identifier
interventional
200
1 country
1
Brief Summary
This study aims to investigate the effectiveness of transdiagnostic nurse-administered 4-session group cognitive behavioral therapy for insomnia (CBT-I) plus standard care, compared to standard care alone, for improving sleep and daytime function, enhancing recovery, preventing relapses, and reducing medication burden in patients with the first episode of mood disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2016
CompletedFirst Posted
Study publicly available on registry
December 22, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedMarch 25, 2020
March 1, 2020
3 years
December 12, 2016
March 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chang of subjects'' self-rated score of severity of insomnia symptoms and functional impairment measured by Insomnia Severity Index (ISI) questionnaire
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Secondary Outcomes (20)
Change of the severity of depression symptoms measured by 17-item Hamilton Depression Rating Scale (HAM-D17)
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of the severity of mania symptoms measured by Young Mania Rating Scale(YMRS)
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of the severity of illness measured by Clinical Global Impressions of Severity (CGI-S)
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of the anxiety and depression state measured by Hospital Anxiety and Depression Scale(HADS)
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
Change of subjects' self-rated severity of physical symptoms measured by Somatic Symptom Inventory (SSI)
Baseline, 3-month post-baseline, 6-month post-baseline, and 12-month post-baseline
- +15 more secondary outcomes
Study Arms (2)
CBT-I plus standard care
EXPERIMENTALThe group CBT-I will receive both CBT-I and standard care. CBT-I covers sleep-wake cycle as well as sleep hygiene education, activity scheduling, stimulus control, sleep restriction, relaxation training, and cognitive therapy. Standard care will include those treatments provided by the psychiatrists according to their clinical needs.
Standard care
NO INTERVENTIONOnly standard care will be provided to this group. Medications will be prescribed and referral to community nurse, social worker and psychologist will be made by the doctors according to their need.
Interventions
This CBT-I is a 4 sessions 60-90 minutes group-based therapy administered by a nurse therapist. Each session has 6-8 participants.
Eligibility Criteria
You may qualify if:
- Hong Kong residents
- Aged ≥ 18 years
- Able to to communicate in Cantonese and write in Chinese
- First episode of depressive or bipolar disorders according to the DSM-5 diagnostic criteria
- Having received psychiatric treatment for less than 12 months
- Meeting the DSM-5 diagnostic criteria for insomnia disorder for at least 1 month, instead of at least 3 months, as in criterion D.
You may not qualify if:
- Significant cognitive impairments and psychotic symptoms, based on a Mini-mental State Examination score of 23 or below and the Positive and Negative Syndrome Scale items on delusions, conceptual disorganization, and hallucinatory behavior at moderate severity or above
- A diagnosis of schizophrenia, delusional disorder, neurocognitive disorders, or learning disability
- Having a highly unstable medical or psychiatric condition (including strong suicidal risk) that requires hospitalization
- Having an untreated sleep disorder, including narcolepsy, obstructive sleep apnea, and periodic leg movement disorder
- Past or current treatment with CBT-I
- Having a fear of speaking in a group setting or refusal to give informed consent
- Refuse to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Kowloon Hospital, Hong Kongcollaborator
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 12, 2016
First Posted
December 22, 2016
Study Start
January 1, 2017
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
March 25, 2020
Record last verified: 2020-03